AIRLINK 212.82 Increased By ▲ 3.27 (1.56%)
BOP 10.25 Decreased By ▼ -0.21 (-2.01%)
CNERGY 7.00 Decreased By ▼ -0.35 (-4.76%)
FCCL 33.47 Decreased By ▼ -0.92 (-2.68%)
FFL 17.64 Decreased By ▼ -0.41 (-2.27%)
FLYNG 21.82 Decreased By ▼ -1.10 (-4.8%)
HUBC 129.11 Decreased By ▼ -3.38 (-2.55%)
HUMNL 13.86 Decreased By ▼ -0.28 (-1.98%)
KEL 4.86 Decreased By ▼ -0.17 (-3.38%)
KOSM 6.93 Decreased By ▼ -0.14 (-1.98%)
MLCF 43.63 Decreased By ▼ -1.57 (-3.47%)
OGDC 212.95 Decreased By ▼ -5.43 (-2.49%)
PACE 7.22 Decreased By ▼ -0.36 (-4.75%)
PAEL 41.17 Decreased By ▼ -0.53 (-1.27%)
PIAHCLA 16.83 Decreased By ▼ -0.47 (-2.72%)
PIBTL 8.63 Increased By ▲ 0.08 (0.94%)
POWERPS 12.50 No Change ▼ 0.00 (0%)
PPL 183.03 Decreased By ▼ -6.00 (-3.17%)
PRL 39.63 Decreased By ▼ -2.70 (-6.38%)
PTC 24.73 Decreased By ▼ -0.44 (-1.75%)
SEARL 98.01 Decreased By ▼ -5.95 (-5.72%)
SILK 1.01 Decreased By ▼ -0.02 (-1.94%)
SSGC 41.73 Increased By ▲ 2.49 (6.35%)
SYM 18.86 Decreased By ▼ -0.30 (-1.57%)
TELE 9.00 Decreased By ▼ -0.24 (-2.6%)
TPLP 12.40 Decreased By ▼ -0.70 (-5.34%)
TRG 65.68 Decreased By ▼ -3.50 (-5.06%)
WAVESAPP 10.98 Increased By ▲ 0.26 (2.43%)
WTL 1.79 Increased By ▲ 0.08 (4.68%)
YOUW 4.03 Decreased By ▼ -0.11 (-2.66%)
BR100 11,866 Decreased By -213.1 (-1.76%)
BR30 35,697 Decreased By -905.3 (-2.47%)
KSE100 114,148 Decreased By -1904.2 (-1.64%)
KSE30 35,952 Decreased By -625.5 (-1.71%)

23andMe, a Google-funded online company selling a $999 DNA test, launched on Monday as a kind of genetics-based MySpace or Facebook that also has the more serious aim of allowing medicine someday to target Americans' ills more precisely.
Users sign up for the DNA saliva test online and receive and return it by mail. Four to six weeks later, the results are online, allowing them to learn about their inherited traits, their ancestry and - likely with the help of a professional to look at the data - some of their personal disease risks.
The Web site, which takes its name from the 23 pairs of chromosomes that make up each person's genome, says it will display more than a half-million data points in users' genomes in a form they can visualise and understand.
"Compare your genetic blueprint to your friends and family," the site invites.
Down the line, when the company's database is much larger, users will have the option to take part in scientific studies that could help researchers determine such things as who is in danger of having a life-threatening drug reaction or who may be more likely to benefit from a specific cancer treatment.
"The mission of 23andMe is to take the genetic revolution to a new level," said 23andMe co-founder Linda Avey. "There wasn't an effective way for people to contribute," said fellow founder Anne Wojcicki, who has a background in health-care investing and is married to Google Inc co-founder Sergey Brin. The site does not now make interpretations about a user's risk for developing such diseases as cancers, Alzheimer's disease, diabetes and others, although users could in some cases get help from genetic counsellors or other experts to make some basic assessments.
While technology has made it easier to find and share information, it has also made security and privacy issues critical. The protection of genetic information is particularly important to many consumers, who fear that insurers or other groups may use genetic data to deny coverage to or discriminate against people predisposed for serious disease.
23andMe's founders say the personal data in their system is secure and under the user's control - protected by more than a dozen levels of authentication and encryption from the lab to the user.

Copyright Reuters, 2007

Comments

Comments are closed.